ImmunoCellular Therapeutics, Ltd. News Headlines

IMUC 
$0.9206
*  
0.0494
5.09%
Get IMUC Alerts
*Delayed - data as of Sep. 18, 2014  -  Find a broker to begin trading IMUC now
Exchange: AMEX
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

ImmunoCellular Therapeutics (IMUC) Jumps: Stock Up 9% - Tale of the Tape
9/18/2014 9:58:00 AM - Zacks.com

ImmunoCellular: Thoughts On Management's Plan To Move ICT-107 Into Phase 3
9/9/2014 10:18:00 AM - Seeking Alpha

Wednesday Sector Laggards: Drugs, Biotechnology Stocks
7/16/2014 3:35:27 PM - BNK Invest

Why Immunotherapies Have Made DelMar's Lead Drug A Necessity In Brain Cancer
7/15/2014 2:40:00 PM - Seeking Alpha

Positive Trends For ImmunoCellular Therapeutics
6/9/2014 10:57:00 AM - Seeking Alpha

Shortage Of R&D At Big Pharma Creates Demand For Small Biotech: Joseph Pantginis
6/6/2014 1:45:00 PM - Seeking Alpha

Monday Sector Laggards: Drugs, Manufacturing Stocks
6/2/2014 3:44:31 PM - BNK Invest

ImmunoCellular Plans To Move ICT-107 Forward Into Phase III Trials Based On New Sub-Group Analysis Presented At ASCO
6/2/2014 11:41:00 AM - Seeking Alpha

ImmunoCellular Plans To Move ICT-107 Forward Into Phase III Trials Based On New Sub-Group Analysis Presented At ASCO
6/2/2014 10:41:45 AM - SeekingAlpha

ImmunoCellular Plans To Move ICT-107 Forward Into Phase III Trials Based On New Sub-Group Analysis Presented At ASCO
6/2/2014 10:41:00 AM - Seeking Alpha

Sector Update: Healthcare Shares Flat Pre-Market; ImmunoCelluar up 12% on Positive Data on Immunotherapeutic Vaccine
6/2/2014 8:56:05 AM - MT Newswires

Sector Update: Healthcare
6/2/2014 8:55:31 AM - MT Newswires

ImmunoCellular Therapeutics: Potential Near-Term Upward Spike
5/20/2014 10:24:00 AM - Seeking Alpha

Refuting The Latest Negative Blog On Northwest Biotherapeutics
4/3/2014 3:50:00 PM - Seeking Alpha

ImmunoCellular: Is Approval Enough?
2/24/2014 10:48:00 AM - Seeking Alpha

Northwest Is A Good Long-Term Bet
2/14/2014 10:57:00 AM - Seeking Alpha

Focus On Cancer Immunotherapy Results
1/25/2014 3:41:00 AM - Seeking Alpha

My 2014 Diversified REIT Portfolio Designed For Outperformance
1/7/2014 1:56:00 AM - Seeking Alpha

Dendritic Cell Vaccines: A Look Back At Clinical Trials Since 1999
1/2/2014 11:46:00 AM - Seeking Alpha

Bristol-Myers Squibb Vs. Roche In The Brain Cancer Race
1/2/2014 8:58:00 AM - Seeking Alpha

Inovio CEO Interview: PD1/PDL1 Inhibitors, Immunotherapy And Why Investors Should Be Excited About 2014
12/20/2013 11:30:00 AM - Seeking Alpha

Immunocellular Shares Are Set For A Rebound
12/20/2013 6:54:00 AM - Seeking Alpha

Celldex: Some Thoughts On Rindopepimut
12/19/2013 12:43:00 PM - SeekingAlpha

Sorting Out Thorny Issues In The Latest Northwest Bio ImmunoCellular Controversy
12/19/2013 12:22:00 PM - Seeking Alpha

Celldex: Some Thoughts On Rindopepimut
12/19/2013 12:16:00 PM - Seeking Alpha